Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

18 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Diphtheria CRM197 Protein Conjugate Articles

FDA To Review Lederle's DTaP-Hib

25 March 1997

CPMP Position On 3rd Generation Contraceptives

3 February 1997

Hibtiter Indications Expanded In UK

16 January 1995

HibTITER Approved For Mixing With DTP

22 August 1994

AHP Bid For Cyanamid Will Broaden Product Range

15 August 1994

CPMP APPROVES LEDERLE'S HIBTITER

25 October 1993

NEW Hib VACCINES CUT DEATH RATE

10 May 1993

LEDERLE-PRAXIS APPROVAL

19 April 1993

MENINGITIS VACCINE IN CANADA

9 March 1992

PRAXIS' HibTITER IN HIV INFECTION

6 January 1992

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS